Literature DB >> 26362002

Referrals and Treatment Completion for Prescription Opioid Admissions: Five Years of National Data.

Barbara St Marie1, Ethan Sahker2, Stephan Arndt3.   

Abstract

This study examines sources of referral for prescription opioid admission to substance use disorder treatment facilities and their relative completion success rates using secondary analysis of an existing data set (treatment episode datasets-discharge). Five years of data from public and private treatment facilities were extracted for client discharges with no prior treatment (N=2,909,884). Healthcare professionals account for very few referrals to treatment (<10%). Prescription opioid clients referred into treatment had lower treatment success compared to other substance clients and when referred by healthcare providers had lower success rates (OR=0.72, 95% CI 0.70-0.75) than clients from other referral sources. Fewer treatment referrals for prescription opioid misuse by healthcare providers and lower success rates are significant and timely findings due to the prevalence of prescription opioid misuse. Healthcare providers are well positioned to refer early for prescription opioid misuse and continue support of their patients during treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Healthcare referral; Prescription opioid; Substance abuse; Treatment outcomes

Mesh:

Year:  2015        PMID: 26362002      PMCID: PMC4704687          DOI: 10.1016/j.jsat.2015.07.010

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  29 in total

1.  Substance use disorder patients who are mandated to treatment: characteristics, treatment process, and 1- and 5-year outcomes.

Authors:  John F Kelly; John W Finney; Rudolf Moos
Journal:  J Subst Abuse Treat       Date:  2005-04

2.  Social pressure, coercion, and client engagement at treatment entry: a self-determination theory perspective.

Authors:  T Cameron Wild; John A Cunningham; Richard M Ryan
Journal:  Addict Behav       Date:  2006-02-09       Impact factor: 3.913

Review 3.  State-level treatment outcome studies using administrative databases.

Authors:  A I Alterman; J Langenbucher; R L Morrison
Journal:  Eval Rev       Date:  2001-04

4.  Probabilistic index: an intuitive non-parametric approach to measuring the size of treatment effects.

Authors:  Laura Acion; John J Peterson; Scott Temple; Stephan Arndt
Journal:  Stat Med       Date:  2006-02-28       Impact factor: 2.373

5.  Screening for alcoholism in the primary care setting: are we talking to the right people?

Authors:  Stephan Arndt; Susan K Schultz; Carolyn Turvey; Amy Petersen
Journal:  J Fam Pract       Date:  2002-01       Impact factor: 0.493

6.  Drug treatment completion and post-discharge employment in the TOPPS-II Interstate Cooperative Study.

Authors:  Amelia M Arria
Journal:  J Subst Abuse Treat       Date:  2003-07

7.  Referral paths, patient profiles and treatment adherence of older alcoholic men.

Authors:  Roland M Atkinson; Sahana Misra; Stephen C Ryan; John A Turner
Journal:  J Subst Abuse Treat       Date:  2003-07

8.  Community referral sources and entry of treatment-naive clients into outpatient addiction treatment.

Authors:  Peter D Friedmann; Stephenie C Lemon; Michael D Stein; Thomas A D'Aunno
Journal:  Am J Drug Alcohol Abuse       Date:  2003       Impact factor: 3.829

9.  Are racial disparities in alcohol treatment completion associated with racial differences in treatment modality entry? Comparison of outpatient treatment and residential treatment in Los Angeles County, 1998 to 2000.

Authors:  Ricky N Bluthenthal; Jerry O Jacobson; Paul L Robinson
Journal:  Alcohol Clin Exp Res       Date:  2007-09-26       Impact factor: 3.455

10.  The influence of legal coercion on dropout from substance abuse treatment: results from a national survey.

Authors:  Brian E Perron; Charlotte L Bright
Journal:  Drug Alcohol Depend       Date:  2007-09-14       Impact factor: 4.492

View more
  8 in total

1.  Racial and ethnic differences in opioid agonist treatment for opioid use disorder in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Michael I Fingerhood; Brendan Saloner
Journal:  Drug Alcohol Depend       Date:  2017-07-11       Impact factor: 4.492

2.  Use and Misuse of Opioid Pain Medications by Pregnant and Nonpregnant Women.

Authors:  Barbara St Marie; Lastascia Coleman; Julie A Vignato; Stephan Arndt; Lisa S Segre
Journal:  Pain Manag Nurs       Date:  2019-06-28       Impact factor: 1.929

Review 3.  Opioid use and misuse: health impact, prevalence, correlates and interventions.

Authors:  Maria Bolshakova; Ricky Bluthenthal; Steve Sussman
Journal:  Psychol Health       Date:  2019-06-08

4.  A state-wide education program on opioid use disorder: influential community members' knowledge, beliefs, and opportunities for coalition development.

Authors:  Lindsey Hohmann; Haley Phillippe; Karen Marlowe; Ruth Jeminiwa; Natalie Hohmann; Salisa Westrick; Amanda Fowler; Brent Fox
Journal:  BMC Public Health       Date:  2022-05-04       Impact factor: 4.135

5.  The association of psychiatric comorbidity with treatment completion among clients admitted to substance use treatment programs in a U.S. national sample.

Authors:  Noa Krawczyk; Kenneth A Feder; Brendan Saloner; Rosa M Crum; Marc Kealhofer; Ramin Mojtabai
Journal:  Drug Alcohol Depend       Date:  2017-04-19       Impact factor: 4.492

6.  Assessing Patients' Risk for Opioid Use Disorder.

Authors:  Barbara St Marie
Journal:  AACN Adv Crit Care       Date:  2019-12-15

7.  Stability of the alcohol use disorders identification test in practical service settings.

Authors:  Ethan Sahker; Donna A Lancianese; Stephan Arndt
Journal:  Subst Abuse Rehabil       Date:  2017-03-24

8.  Black girls and referrals: racial and gender disparities in self-reported referral to substance use disorder assessment among justice-involved children.

Authors:  Micah E Johnson; Shawnta L Lloyd; Skye C Bristol; Amy L Elliott; Linda B Cottler
Journal:  Subst Abuse Treat Prev Policy       Date:  2022-10-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.